Also trades as: 1093.HK (HKSE) · $vol 130M · CSPCY (OTC) · $vol 0M

$1.11

+0.00 (+0.00%)

OTC · Healthcare · Drug Manufacturers - General · Tech Score Neutral · Power 54 · $12.7B mcap · 7.63B float · 0.0000% daily turnover · Short 100% of daily vol

Overview Chart Smart Money Financials Income Statement Cash Flow Balance Sheet Earnings

Analysis Technicals Weather Peers ESG Institutions Dark Pool Short Interest

Income Trends

Revenue

$28.2B -8.7% ▼

5Y CAGR: -1.0%

Gross Profit

$18.5B -14.4% ▼

5Y CAGR: -2.5%

Operating Income

$4.3B -24.6% ▼

5Y CAGR: -7.9%

Net Income

$4.2B -8.6% ▼

5Y CAGR: -4.0%

EPS (Diluted)

$0.37 -5.1% ▼

5Y CAGR: -3.0%

EBITDA

$5.8B -15.0% ▼

5Y CAGR: -6.3%

Profit Margins

Year-over-Year Growth

View Full Income Statement

Line Item	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$34.2B	$35.0B	$34.6B	$30.9B	$28.2B
YoY Growth	+15.4%	+2.4%	-1.2%	-10.8%	-8.7%
Cost of Revenue	$8.1B	$8.9B	$10.2B	$9.3B	$9.7B
Gross Profit	$25.5B	$22.7B	$24.4B	$21.6B	$18.5B
Gross Margin	74.5%	64.9%	70.5%	70.0%	65.6%
R&D Expenses	$4.2B	$4.6B	$5.3B	$5.5B	$6.3B
SG&A Expenses	$14.1B	$13.0B	$11.4B	$10.4B	$7.9B
Operating Expenses	$18.3B	$17.6B	$16.7B	$15.9B	$14.2B
Operating Income	$7.7B	$7.6B	$7.7B	$5.7B	$4.3B
Operating Margin	22.4%	21.7%	22.2%	18.5%	15.3%
Interest Expense	$8M	$25M	$26M	$44M	$42M
Income Before Tax	$8.4B	$8.6B	$7.4B	$5.9B	$5.2B
Tax Expense	$1.4B	$1.4B	$1.3B	$1.3B	$1.0B
Net Income	$6.9B	$6.9B	$5.9B	$4.6B	$4.2B
Net Margin	20.1%	19.7%	17.0%	14.9%	14.9%
EPS (Diluted)	$0.47	$0.51	$0.49	$0.39	$0.37
EBITDA	$9.3B	$8.7B	$8.5B	$6.9B	$5.8B
Shares Outstanding	11.95B	11.92B	11.87B	11.74B	11.42B

Line Item	FY2022 Q4	FY2023 Q2	FY2023 Q4	FY2024 Q2	FY2024 Q4	FY2025 Q2	FY2025 Q4	FY2026 Q2
Revenue	$15.1B	$8.0B	$7.6B	$16.3B	$14.6B	$1.8B	$12.5B	$18.3B
Cost of Revenue	$4.3B	$2.3B	$7.9B	$4.6B	$4.6B	$5.0B	$4.3B	$4.4B
Gross Profit	$10.8B	$5.7B	$18.7B	$11.6B	$10.0B	$9.5B	$8.2B	$14.0B
Gross Margin	71.2%	71.2%	246.3%	71.6%	68.2%	525.7%	65.6%	76.2%
R&D Expenses	$1.1B	$1.3B	$1.2B	$2.5B	$3.0B	$367M	$3.1B	$3.0B
SG&A Expenses	$6.3B	$5.9B	$5.4B	$5.8B	$4.6B	$473M	$3.8B	$3.7B
Operating Expenses	$8.7B	$5.7B	$3.6B	$8.4B	$7.5B	$6.7B	$6.8B	$6.7B
Operating Income	$1.6B	$0	$1.8B	$3.7B	$2.0B	$2.8B	$1.4B	$7.2B
Operating Margin	10.5%	0.0%	23.6%	22.7%	13.8%	155.5%	11.0%	39.5%
Interest Expense	$15M	$6M	$9M	$0	$0	$3M	$17M	$13M
Income Before Tax	$3.8B	$1.9B	$1.8B	$3.8B	$2.1B	$426M	$1.7B	$7.4B
Tax Expense	$648M	$312M	$1.0B	$749M	$570M	$596M	$382M	$1.1B
Net Income	$1.6B	$1.5B	$1.4B	$3.0B	$1.6B	$349M	$1.3B	$6.0B
Net Margin	10.8%	19.2%	18.2%	18.5%	10.9%	19.2%	10.5%	32.8%
EPS (Diluted)	$0.25	$0.13	$0.36	$0.27	$0.12	$0.03	$0.12	$0.53
EBITDA	$2.6B	$1.9B	$1.8B	$4.4B	$2.5B	$3.5B	$2.1B	$7.9B
Shares Outstanding	11.93B	11.90B	11.85B	11.84B	11.74B	11.43B	11.52B	11.42B

CHJTF OTC

Income Trends

Profit Margins

Year-over-Year Growth

Sign in to InsiderStreet